Navigation Links
Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Date:10/21/2010

>9 Selecting Cancer Indications for Cancer Vaccine Drugs 339

9.1 Acute Lymphocytic Leukemia 342

9.2 Acute Myelogenous Leukemia 343

9.3 Anal Dysplasia 344

9.4 B-cell Lymphoma 344

9.5 Bladder Cancer 345

9.6 Bone Cancer 346

9.7 Brain Cancer 346

9.8 Breast Cancer 347

9.9 Cancer (general) 349

9.10 Cervical Cancer 350

9.11 Chemotherapy-induced Bone Marrow Injury (general) 351

9.12 Cervical Dysplasia 352

9.13 Chronic Myelogenous Leukemia 353

9.14 Colorectal Cancer 354

9.15 Gastrointestinal Cancer (general) 356

9.16 Gastrointestinal Stomach Cancer 356

9.17 Head and Neck Cancer 357

9.18 Hematological Cancer (general) 358

9.19 Leukemia (general) 358

9.20 Liver Cancer 359

9.21 Lung Cancer (general) 360

9.22 Lymphoma (general) 361

9.23 Melanoma 362

9.24 Mesothelioma 364

9.25 Myelodysplastic Syndrome 364

9.26 Myeloma 365

9.27 non-Hodgkin's Lymphoma 366

9.28 Non-Small Cell Lung Cancer 367

9.29 Oesophageal Cancer 369

9.30 Osteo Sarcoma 370

9.31 Ovarian Cancer 371

9.32 Pancreatic Cancer 374

9.33 Prostate Cancer 376

9.34 Renal Cancer 379

9.35 Skin Cancer (general) 381

9.36 Small Cell Lung Cancer 381

9.37 Soft Tissue Sarcoma 381

9.38 Solid Tumor 381

9.39 Squamous Cell Cancer 382

9.40 Thyroid Cancer 382

9.41 Unspecified Cancer Indication 383

9.42 Vaccine adjunct 386

10 Pipeline and Portfolio Planning: Competitive Benchmarking of the Cancer Vaccine Drug Pipeline by Investigator 387

10.1 Competitive Fall-Out Assessment 387

10.2 Changes in the Competitive Landscape: M&A, Bankruptcy and Name Change 389

10.3 AC Immune 390

10.4 Adaptimmune 392

10.5 Aduro BioTech 395

10.6 Advaxis 397

10.7 Aida Pharmaceuticals 402

10.8 Akela Pharma 404'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 20, 2015 Research and Markets ( ... "Key Pharma News Issue" newsletter to ... Gilead Sciences, burgeoning oncology pipeline and serves as ... oncology deals in 2015, with a large-scale potentially ... Key Pharma News covers all major ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
(Date:7/27/2015)... IRVINE, Calif. , July 27, 2015 ... ELOS ) , a global market leader in ... has received Korean Ministry of Food and Drug Safety ... this regulatory clearance, the Company can fulfill PicoWay orders ... activity in Korea anticipated later in the third quarter ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
(Date:7/28/2015)... ... July 28, 2015 , ... Scientel is thrilled ... Conference, August 18-20 at the McHenry Convention Center in San Jose, Ca. Scientel ... #104. , Scientel’s presentation on Multi-Modeling and the industry’s first polymorphic database will address ...
(Date:7/27/2015)... SC (PRWEB) , ... July 28, 2015 , ... ... P.A., announced that his practice has teamed up with Realief Neuropathy Centers in order ... been shown to reverse the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular ... smaller regional brain volumes that may be early indicators of Alzheimer’s disease and ... already know that vascular risk factors damage the brain and can result in ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... especially in wound center management. Earlier this year Wound Care Advantage ... and training for WCA wound centers. Customized learning paths allow for clinicians, ...
(Date:7/27/2015)... ... July 27, 2015 , ... On July 14, 2015, ... Common Skin Issues,” describes common skin issues such as stretch marks , ... dermatologists to treat them. The treatment options listed include lasers, ultrasound, radio frequency, Botox, ...
Breaking Medicine News(10 mins):Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2
... availability of Trade Alerts on stocks making news ... notes for free by visiting: http://www.BeaconEquity.com/m Today,s ... Board: UVSE), Green Earth Technologies Inc. (Pink Sheets: ... Gulf Ethanol Corp. (Pink Sheets: GFET), YTB International ...
... 13 Founders Club will donate $5 from the sale ... at St. Joseph,s/Candler. "The Mammography Fund is a great ... fight against cancer," Jeff Andrews, CEO of Founders Club, said.The ... Edwin Watts Golf stores and specialty golf retail stores across ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today ... share. This dividend was declared by Hill-Rom,s Board of Directors ... 2009 to shareholders of record as of March 17, 2009. ... is a leading worldwide manufacturer and provider of medical technologies ...
... along with being sweet , , FRIDAY, Feb. 13 (HealthDay News) ... than sweet; it could help guard your true love against ... in addition to being decadent and delicious, moderate amounts of ... Scroggs, a health education manager at the University of Texas ...
... (NYSE Alternext: FHC) announced today that its stock repurchase ... until December 31, 2010. The program was initiated in ... the Company,s common stock through December 31, 2008. In ... and extended until December 31, 2009. Through January 31, ...
... announces that it has implemented cost-cutting measures in order ... will continue to seek financing and will initiate a ... of the Company. , Haemacure has been seeking financing ... expressed interest in an equity financing; however, this interest ...
Cached Medicine News:Health News:Technical Trade Alerts on BeaconEquity OTC Gainers: UVSE, GETG, SRCH, GFET, YTBLA, NTRZ 2Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2Health News:Chocolate for Your Valentine a Healthy Idea 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 3Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 2Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 3
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: